Biohaven Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biohaven Ltd. (BHVN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-846.42-408.17-570.28-213.80-118.67
Depreciation & Amortization7.866.911.391.390.07
Stock Based Compensation71.9628.79193.5665.6429.50
Change in Working Capital16.8124.61-28.601.668.98
Change in Accounts Payable0.714.875.931.030.22
Change in Other Working Capital68.4819.742.514.528.76
Other Operating Activities68.4844.922.514.520.00
Net Cash from Operating Activities-582.45-331.73-297.69-145.84-75.96
Investing Activities
Capital Expenditures-4.05-3.05-41.07-0.94-2.70
Acquisitions0.390.00-39.001.880.00
Purchases of Investments-745.68132.88-263.720.000.00
Sales/Maturities of Investments504.36327.00-259.720.000.00
Net Cash from Investing Activities-244.97129.83-304.790.94-2.70
Financing Activities
Common Stock Issued666.17247.92283.800.400.00
Other Financing Activities0.11-36.01483.34138.45152.24
Net Cash from Financing Activities677.77211.91767.60138.45152.24
Summary
Effect of Forex Changes on Cash0.08-0.500.430.000.00
Net Change in Cash-149.659.52165.12-6.4573.59
Cash at Beginning of Period252.12242.6077.0683.510.00
Cash at End of Period102.54-331.73242.6077.060.00
Free Cash Flow-586.50-331.73-338.76-146.78-78.65
Supplemental Disclosures
Interest Paid0.130.000.000.110.00
Income Taxes Paid-10.44-33.3038.1716.592.76